Tenvir Em tablets contain emtricitabine and tenofovir
Tenvir-EM is a combination drug consisting of two antiretroviral drugs, tenofovir and emtricitabine, used in treatment of HIV. This drug does not cure HIV or AIDS and it does not kill the virus once it enters the body, Buy Cipla Truvada tablets online but it does prevent the infection from spreading and it prevents some of the complications associated with HIV. It can be used as a pre-exposure prophylaxis against HIV.
Cipla Truvada tablet dosage , uses and side effects - Classification and Mechanism of Action
Tenvir-EM (Emtricitabine and Tenofovir Disoproxil Fumarate) is a fixed combination drug that has two active ingredients ‚Äì emtricitabine (trade name Emtriva), a nucleoside reverse transcriptase inhibitor and tenofovir, which is a nucleotide reverse transcriptase inhibitor. These two drugs together work by slowing down the growth and multiplication of the HIV as they interfere with one of the crucial enzymes for the functioning of the virus. It works best when combined with other HIV drugs, such as protease inhibitors.
How to take it
Buy Cipla Truvada tablets online is an oral medication that should be swallowed whole, not chewed or sucked, with some water. Make sure to take this drug as prescribed, in regular intervals, since it works best when there is a constant concentration of it in the body.
Tenvir-em contains 200 mg of emtricitabine and 300 mg of tenofovir. The recommended dosage children and adults with body weight of 35 kg (77 lb) or higher is one tablet per day. The dosage should be adjusted for patients with smaller body weight or impaired kidney or liver function.
Before starting using Tenvir-EM (Emtricitabine and Tenofovir Disoproxil Fumarate), inform your doctor of any other medical condition you might be suffering from, especially pancreatitis, liver problems, bone problems, alcoholism and kidney disease. Breastfeeding is not recommended during treatment. The use of this drug in pregnancy is encouraged in HIV-infected mothers since it reduces the chance of passing the virus to the baby. This drug may interact adversely with medications such as aminoglycosides, cyclosporine, amphotercin B, NSAIDs and tacrolimus, or lower the effectiveness of other drugs, such as atanazavir.
Tenvir-em cipla tablets are a fixed dose combination treatment for Human Immunodeficiency Virus (HIV) infection in adults over age 18. Tenvir-EM tablets are used combination with other medications that have a different mechanism of action to the components in Tenvir-EM, and are used to treat patients with HIV infection who have either already received treatment with other medications for HIV or as first line therapy for treatment-inexperienced patients. HIV impairs the immune system by attacking specific immune cells called CD4+ cells that are involved in fighting infection and this can lead to opportunistic life-threatening infection (infections that would not normally be harmful); also if too many CD4+ cells are destroyed this can result in acquired immune deficiency syndrome (AIDS).
Tenvir EM is used as part of a regiment of antiretroviral medications to treat HIV-1 in adults over 18. A single pill contains a combination of two anti-HIV drugs, emtricitabine and tenofovir disoproxil fumarate; however, Tenvir EM must be taken with at least one other anti-HIV medication to prevent HIV from progressing to AIDS.
Tenvir EM is taken orally once a day, at the same time every day, with or without food. Because Tenovir can cause renal impairment, patients with a creatinine clearance of 30 to 49 ml/min should only take one tablet every 48 hours, and patients with a creatinine clearance of less than 30 ml/min should not take Tenvir EM at all.
Patients hypersensitive to either emtricitabine or tenofovir disoproxil fumarate should not take Tenvir EM.
Tenvir-EM is a type of medicine called an HIV-1 (human immunodeficiency virus) nucleoside analog reverse transcriptase inhibitor (NRTI). It contains a combination of two active ingredients - Emtricitabine (known under the brand Emtriva®) and tenofovir disoproxil fumarate, or tenofovir DF (known under the brand Viread®). Tenvir-EM is always used in combination with other anti-HIV-1 medicines to treat adult patients between the ages of 18 - 65 years diagnosed with HIV-1 infection. HIV infection destroys CD4+ T cells, which are important to the immune system. The immune system helps fight infection. After a large number of T cells are destroyed by the HIV-1 virus, the patient gradually develops acquired immune deficiency syndrome (AIDS).
Tenvir-EM does not cure HIV-1 infection or AIDS. The long-term effects of Tenvir-EM are not known at this time. People taking Tenvir-EM may still get opportunistic infections or other conditions that occur during HIV-1 infection. Opportunistic infections develop due to the weak immune system. Some of these conditions are pneumonia, herpes virus infections, and Mycobacterium avium complex (MAC) infection. It is very important that you see your healthcare provider regularly while taking Tenvir-EM.
Tenvir-EM does not lower your risk of transmitting HIV-1 virus to other people through sexual contact, sharing needles, or being exposed to your blood. For the benefit of your health and the health of others, it is important to always practice safe sex by using latex or polyurethane condom or other barrier methods to lower the risk of sexual contact with semen, vaginal secretions, or blood. Never use or share dirty needles. In our online pharmacy, Generic Truvada is available as Tenvir-EM in strength of 300 mg (Tenofovir 300 mg and Emtricitabine 200 mg). We also have in stock Generic Viread (Tenvir by Cipla) which is also used for the same indications.
Tenvir-em cipla tablets prevent or slow down the ability of HIV to replicate and spread, which keeps the amount of virus down to a low level and this results in an increase in CD4 cell numbers, so that the immune system can recover, reducing the risk of disease progression. Tenvir-EM may be used for Pre-exposure prophylaxis (PrEP) treatment. PrEP is a new prevention method in which people who do not have an HIV infection, but may be at high risk, take a Tenvir-EM tablet every day to reduce their risk of becoming infected. Anyone undergoing PrEp treatment should see their healthcare provider every three months for follow-up and testing.
You must commit to taking Tenvir-EM every day and seeing your doctor every three months for follow up care and testing. How to Get Started: Please contact your doctor to discuss and have a HIV test as soon as possible. Tenvir-EM is for individuals for high exposure risk for HIV-1. tenvir em must be taken every day along with safer sex practices. Please take the time to educate yourself about safe sex and ask your doctor for advice.
Tenvir em tablets contain a combination of two antiretroviral drugs, emtricitabine and tenofovir disoproxil fumarate, which are only effective against RNA viruses (retroviruses) like Human Immunodeficiency Virus (HIV). These drugs each work by inhibiting the action of the viral-specific enzyme reverse transcriptase (RT), which is needed for the virus to be able to replicate. Retroviruses convert RNA to DNA, which is then integrated into the DNA of infected immune cells so that the virus can replicate.
Visit To The Website for getting more information related to Cipla Truvada.